JANUX THERAPEUTICS

janux-therapeutics-logo

Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient’s healthy tissue. Janux technology targets all three stages of the anti-tumor immune response.
#SimilarOrganizations #People #Financial #Event #Website #More

JANUX THERAPEUTICS

Social Links:

linkedin

Linkedin

Industry:
Biotechnology Health Diagnostics Pharmaceutical Therapeutics

Founded:
2017-01-01

Address:
La Jolla, California, United States

Country:
United States

Website Url:
http://www.januxrx.com

Total Employee:
11+

Status:
Active

Contact:
858-750-4700

Total Funding:
192.44 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

obsidian-therapeutics-logo

Obsidian Therapeutics

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

radius-health-logo

Radius Health

Radius Health develops drug therapies for osteoporosis and women’s health.

Current Employees Featured

david-campbell_image

David Campbell
David Campbell President, CEO, Director, and Founder @ Janux Therapeutics
President, CEO, Director, and Founder
2017-05-01

byron-robinson_image

Byron Robinson
Byron Robinson Chief Strategy Officer @ Janux Therapeutics
Chief Strategy Officer
2022-02-01

Founder


david-campbell_image

David Campbell

Stock Details


Company's stock symbol is NASDAQ:JANX

Investors List

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - Janux Therapeutics

bvf-partners_image

BVF Partners

BVF Partners investment in Series B - Janux Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - Janux Therapeutics

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Series B - Janux Therapeutics

hartford-healthcare-endowment_image

Hartford HealthCare Endowment

Hartford HealthCare Endowment investment in Series B - Janux Therapeutics

bregua-corporation_image

Bregua Corporation

Bregua Corporation investment in Series B - Janux Therapeutics

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series B - Janux Therapeutics

logos-capital_image

Logos Capital

Logos Capital investment in Series B - Janux Therapeutics

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series B - Janux Therapeutics

avalon-ventures_image

Avalon Ventures

Avalon Ventures investment in Series B - Janux Therapeutics

Official Site Inspections

http://www.januxrx.com Semrush global rank: 4.53 M Semrush visits lastest month: 2.33 K

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Janux Therapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved